PetMed Express (NASDAQ:PETS) Shares Pass Above Two Hundred Day Moving Average – Should You Sell?

PetMed Express, Inc. (NASDAQ:PETS)’s stock price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $4.15 and traded as high as $4.82. PetMed Express shares last traded at $4.77, with a volume of 131,466 shares changing hands.

Analysts Set New Price Targets

Separately, StockNews.com upgraded PetMed Express from a “hold” rating to a “buy” rating in a research report on Tuesday, November 12th.

PetMed Express Price Performance

The firm’s 50-day simple moving average is $5.05 and its 200 day simple moving average is $4.15. The firm has a market capitalization of $98.56 million, a price-to-earnings ratio of -79.50 and a beta of 0.69.

PetMed Express (NASDAQ:PETS) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $0.11 earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.17. PetMed Express had a negative return on equity of 1.00% and a negative net margin of 0.37%. The business had revenue of $59.57 million during the quarter, compared to the consensus estimate of $66.02 million. As a group, research analysts predict that PetMed Express, Inc. will post 0.24 earnings per share for the current year.

Insider Activity at PetMed Express

In other news, Director Leslie C.G. Campbell purchased 15,000 shares of PetMed Express stock in a transaction dated Wednesday, December 4th. The shares were bought at an average cost of $5.38 per share, for a total transaction of $80,700.00. Following the completion of the acquisition, the director now owns 70,000 shares in the company, valued at approximately $376,600. This trade represents a 27.27 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.10% of the stock is currently owned by insiders.

Institutional Trading of PetMed Express

Institutional investors have recently added to or reduced their stakes in the stock. Point72 DIFC Ltd bought a new position in shares of PetMed Express during the 2nd quarter worth approximately $34,000. Marshall Wace LLP bought a new position in PetMed Express during the second quarter worth $46,000. Independent Advisor Alliance acquired a new stake in PetMed Express in the third quarter worth $106,000. Point72 Asia Singapore Pte. Ltd. bought a new stake in PetMed Express in the second quarter valued at $135,000. Finally, Sei Investments Co. increased its stake in PetMed Express by 8.3% in the second quarter. Sei Investments Co. now owns 44,220 shares of the company’s stock valued at $179,000 after purchasing an additional 3,400 shares in the last quarter. 73.33% of the stock is currently owned by institutional investors.

About PetMed Express

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.